Printer Friendly
The Free Library
4,488,568 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Four antiretrovirals reduced to three after 48 weeks.


A trial started over 400 antiretroviral antiretroviral /an·ti·ret·ro·vi·ral/ (-ret´ro-vi?ral) effective against retroviruses, or an agent with this quality.

an·ti·ret·ro·vi·ral (n
-naive patients on an intensive 4-drug regimen--Trizivir, (AZT AZT - Azido-Thymidine (AIDS drug)
AZT - Aschheim-Zondek Test
, 3TC, and abacavir abacavir /abac·a·vir/ (ah-bak´ah-vir) a nonnucleoside reverse transcriptase inhibitor used as the sulfate salt as an antiretroviral in the treatment of human immunodeficiency virus infection.) together with Sustiva (efavirenz efavirenz /ef·a·vi·renz/ (ef´ah-vi?renz) an antiretroviral, inhibiting reverse transcriptase; used in the treatment of HIV infection.

e·fa·vir·enz (-fä
). After 48 weeks, 282 of them were randomized to either continue that regimen, or to drop the Sustiva, for another 48 weeks in the study. "After induction with ABC/3TC/ZDV + EFV EFV - Electric-Field-Variant Function
EFV - Enhanced Fixed Variable (rate)
EFV - Expeditionary Fighting Vehicle
, simplification to ABC/3TC/ZDV alone maintained virologic control and immunologic response, reduced fasting lipids and ART-associated adverse events, and improved adherence" (quoted from abstract).

There were more virologic failures in the group that dropped the Sustiva and switched to three drugs (16 vs. 8), but this difference did not reach statistical significance (P = 0.134).

Markowitz Markowitz - The author of the original Simscript language. M, Hill-Zabala C, Lang J, and others, for the ESS40013 study team. Induction With Abacavir/Lamivudine lamivudine /la·miv·u·dine/ (lah-miv´u-den) a nucleoside analogue that inhibits reverse transcriptase, used as an antiviral agent in the treatment of chronic hepatitis B and, in combination with zidovudine, the treatment of HIV infection and AIDS.

la·miv·u·dine 
/Zidovudine Plus Efavirenz for 48 Weeks Followed by 48-Week Maintenance With Abacavir/Lamivudine/Zidovudine Alone in Antiretroviral-Naive HIV-l-Infected Patients. JAIDS JAIDS - Journal of Acquired Immune Deficiency Syndromes (Journal of Acquired Immune Deficiency immune deficiency
n.
See immunodeficiency.
 Syndromes). July 1, 3005; volume 39, number 3, pages 257-264.
COPYRIGHT 2005 John S. James
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2005, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Author:James, John S.
Publication:AIDS Treatment News
Article Type:Brief Article
Geographic Code:1USA
Date:Jun 24, 2005
Words:160
Previous Article:Immunology study finds decreased activation markers related to better viral control.
Next Article:UK HIV liver transplant guidelines published.(guidelines for liver transplantation in patients with HIV infection)(Brief Article)
Topics:



Related Articles
Retroviruses Conference: Johns Hopkins Report.(Hopkins HIV Report)
Therapeutic Drug Monitoring: Medscape Web Resource Page.
Subset analysis.(research on long-term effects of antiretroviral therapy)(Brief Article)
NIH 7-Day On-Off Trial May Reduce Drug Side Effects, Cost; Why It's Not Ready for Use.(National Institutes of Health antiretroviral study)
New kinds of treatment.
HIV medicine after Barcelona conference: interview with Howard Grossman, M.D.
Prevention: New approach will test tenofovir for persons at high risk.(Brief Article)
Antiretroviral pipeline: new-drug reports from retroviruses conference.
Treatment interruption: most patients could not maintain immune control.
Study finds 3,000,000 years of life saved by HIV treatment in the U.S.

Terms of use | Copyright © 2008 Farlex, Inc. | Feedback | For webmasters | Submit articles